- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: EGFR activating mutation
Total 4399 results
-
Verastem, Inc.CompletedNon Small Cell Lung Cancer | KRAS Activating MutationUnited States, Spain, France, Germany, Italy
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkActive, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
Duke UniversityTerminatedNon Small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingEGFR NP_005219.2:p.S492R | KRAS Gene Mutation | MAP2K1 Gene Mutation | Metastatic Colorectal Adenocarcinoma | Refractory Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7United States
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
Jonsson Comprehensive Cancer CenterAstraZenecaActive, not recruitingGlioblastoma | Recurrent Glioblastoma | EGFR Gene Mutation | Supratentorial Glioblastoma | EGFR Gene Amplification | TP53 wt AlleleUnited States
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior TherapiesUnited States
-
Novartis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungBelgium, Germany, Italy, France, Netherlands, Spain, Korea, Republic of, India, Brazil, Portugal
-
Thoraxklinik-Heidelberg gGmbHAstraZenecaCompletedEGFR Positive Non-small Cell Lung CancerGermany
-
Sheba Medical CenterAstraZenecaSuspendedCarcinoma, Non-Small-Cell Lung | Genes, erbB-1Israel
-
Turning Point Therapeutics, Inc.Active, not recruitingAdvanced Solid Tumor | Metastatic Solid Tumors | MET Gene AlterationsUnited States, France, Korea, Democratic People's Republic of, Korea, Republic of, Spain
-
TYK Medicines, IncCompleted
-
Sumitomo Pharma America, Inc.CompletedAdvanced Solid Tumors | Recurrent Ovarian Carcinoma | Colorectal Carcinoma | EGFR Positive Non-small Cell Lung Cancer | BRAF-Mutated MelanomaUnited States
-
ETOP IBCSG Partners FoundationAstraZenecaActive, not recruitingNSCLC Stage IV | EGFR Gene MutationSingapore, Sweden, Korea, Republic of, Spain, Switzerland, Netherlands, Italy, Poland
-
Boehringer IngelheimCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Pharmacyclics LLC.Completed
-
Betta Pharmaceuticals Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer | EGFR Gene MutationChina
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia
-
TakedaWithdrawnNon-small Cell Lung Cancer (NSCLC)China
-
Duke UniversityCompletedA Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR MutationsNon Small Cell Lung CancerUnited States
-
Roswell Park Cancer InstituteCompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | EGFR Gene MutationUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedNon-Small-Cell Lung CarcinomaUnited States, China, Taiwan, Spain, Korea, Republic of, France, Canada, Hong Kong, Japan, Singapore
-
Sameek RoychowdhuryActive, not recruiting
-
Zhejiang Cancer HospitalCompleted
-
Beta Pharma ShanghaiActive, not recruiting
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Yuhan CorporationCompleted
-
xCuresCancer CommonsAvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesMelanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditionsUnited States
-
AstraZenecaCompletedNon-small Cell Lung CancerVietnam, Turkey, Philippines, Thailand, Egypt, Singapore, India, Peru, Argentina, Chile, Colombia, Costa Rica, Dominican Republic, Kuwait, Mexico
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR T790M+ NSCLCCanada, Korea, Republic of, Taiwan
-
Erasca, Inc.CompletedAdvanced Non-squamous Non-small-cell Lung CancerUnited States
-
Collin BlakelyPuma Biotechnology, Inc.Active, not recruitingLung Cancer Metastatic | EGFR Gene MutationUnited States
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedCarcinoma, Non-Small-Cell Lung | KRAS Gene Mutation | ALK Gene Mutation | BRAF Gene MutationFrance
-
Spectrum Pharmaceuticals, IncTerminated
-
Fudan UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedLung Cancer | Lung Cancer Metastatic | EGFR Gene MutationUnited States
-
Revolution Medicines, Inc.SanofiCompletedSolid TumorUnited States, Korea, Republic of
-
Yonsei UniversityWithdrawnRecurrent/Advanced Gastric CancerKorea, Republic of
-
Michael HoppBoehringer IngelheimActive, not recruiting
-
Boehringer IngelheimCompletedNon-squamous, Non-Small Cell Lung CancerUnited Kingdom
-
Samsung Medical CenterWithdrawnLung CancerKorea, Republic of
-
G1 Therapeutics, Inc.CompletedCarcinoma, Non-Small-Cell Lung | Lung Cancer | Non-small Cell Lung CancerUnited States
-
University of SydneyAstraZeneca; Australasian Lung Cancer Trials GroupActive, not recruitingEGFR Mutant Advanced Non Small Cell Lung CancerTaiwan, Australia
-
First Affiliated Hospital of Zhejiang UniversityEnrolling by invitationNon Small Cell Lung CancerChina
-
Royal Cornwall Hospitals TrustBiocartisCompletedPancreatic Adenocarcinoma | Lung CancerUnited Kingdom
-
National Cancer Institute, NaplesActive, not recruitingNon-squamous Non-small Cell Lung CancerItaly
-
Incyte CorporationTerminatedSolid Tumor MalignancyUnited States, France, United Kingdom, Italy, Korea, Republic of, Japan, Spain, Israel, Denmark, Germany, Switzerland
-
First Affiliated Hospital of Zhejiang UniversityAstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell LungChina
-
Dizal PharmaceuticalsActive, not recruitingNon-Small Cell Lung CancerChina
-
H. Lee Moffitt Cancer Center and Research InstituteArray BioPharmaCompletedNon-Small Cell Lung Cancer | Lung CancerUnited States